{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:06:07Z","timestamp":1787166367535,"version":"build-2736575974"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[1992,9,1]],"date-time":"1992-09-01T00:00:00Z","timestamp":715305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000},"content-version":"vor","delay-in-days":9990,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1992,9]]},"DOI":"10.1093\/annonc\/3.suppl_4.s117","type":"journal-article","created":{"date-parts":[[2012,11,19]],"date-time":"2012-11-19T16:53:08Z","timestamp":1353343988000},"page":"S117-S128","source":"Crossref","is-referenced-by-count":165,"special_numbering":"S4","title":["Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease"],"prefix":"10.1016","volume":"3","author":[{"given":"M.","family":"Henry-Amar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0005","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1056\/NEJM199203053261006","article-title":"Hodgkin\u2019s disease","volume":"326","author":"Urba","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0010","series-title":"Lyon, International Agency for Research on Cancer","article-title":"Cancer Incidence in Five Continents, Vol V. World Health Organization, IARC Scientific Publications n. 88","author":"Muir","year":"1987"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0015","first-page":"676","article-title":"Acute myeloid leukemia following treatment of Hodgkin\u2019s disease","volume":"50","author":"Gr\u00fcnwald","year":"1982","journal-title":"A review. Cancer"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0020","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1056\/NEJM198210143071601","article-title":"Incidence of acute non-lymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin\u2019s disease","volume":"307","author":"Pedersen-Bjergaard","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0025","first-page":"1023","article-title":"Second malignancies complicating Hodgkin\u2019s disease: A Southwest Oncology Group 10-year follow-up","volume":"66","author":"Coltman","year":"1982","journal-title":"Cancer Treat Rep"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0030","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1200\/JCO.1986.4.6.830","article-title":"Second acute leukemia and other malignancies following treatment for Hodgkin\u2019s disease","volume":"4","author":"Valagussa","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0035","first-page":"83","article-title":"Risk of therapy-related leukaemia and preleukaemia after Hodgkin\u2019s disease","volume":"2","author":"Pedersen-Bjergaard","year":"1987","journal-title":"Relation to age, cumulative dose of alkylating agents, and time from chemotherapy. Lancet"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0040","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1200\/JCO.1989.7.8.1046","article-title":"Increased risk of lung cancer, non-Hodgkin\u2019s lymphoma, and leukemia following Hodgkin\u2019s disease","volume":"7","author":"Van Leeuwen","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0045","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM197712082972303","article-title":"Hematologic neoplasia in patients treated for Hodgkin\u2019s disease","volume":"297","author":"Coleman","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0050","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/bmj.280.6209.216","article-title":"Second malignancies in Hodgkin\u2019s disease: A complication of certain forms of treatment","volume":"1","author":"Valagussa","year":"1980","journal-title":"Br Med J"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0055","first-page":"733","article-title":"Leukaemias, non-Hodgkin\u2019s lymphomas and solid tumors in patients treated for Hodgkin\u2019s disease","volume":"1","author":"Coleman","year":"1982","journal-title":"Cancer Surv"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0060","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0002-9343(83)90348-0","article-title":"Acute nonlymphocytic leukemia after treatment for Hodgkin\u2019s disease","volume":"75","author":"Aisenberg","year":"1983","journal-title":"Am J Med"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0065","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2141.1984.tb06057.x","article-title":"Acute leukaemia in patients treated for Hodgkin\u2019s disease","volume":"58","author":"Papa","year":"1984","journal-title":"Brit J Haematol"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bib0005","series-title":"Radiation Carcinogenesis: Epidemiology and Biological Significance","first-page":"181","article-title":"Second cancers after treatment for Hodgkin\u2019s disease: A review","author":"Boivin","year":"1984"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0070","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1200\/JCO.1984.2.7.762","article-title":"Second malignant neoplasms complicating Hodgkin\u2019s disease: The National Cancer Institute Experience","volume":"2","author":"Tester","year":"1984","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0075","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1200\/JCO.1990.8.7.1148","article-title":"Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin\u2019s disease","volume":"8","author":"Andneu","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0080","first-page":"911","article-title":"Second cancer after radiotherapy and chemotherapy for early stages of Hodgkin\u2019s disease","volume":"71","author":"Henry-Amar","year":"1983","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0085","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1136\/bmj.301.6760.1077","article-title":"Leukaemia complicating treatment for Hodgkin\u2019s disease: The experience of the British National Lymphoma Investigation","volume":"301","author":"Devereux","year":"1990","journal-title":"Br Med J"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0090","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0140-6736(87)90782-3","article-title":"Splenectomy in Hodgkin\u2019s disease and second leukaemias","volume":"2","author":"Van Leeuwen","year":"1987","journal-title":"Lancet"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0095","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ijc.2910420218","article-title":"Subsequent development of acute non-lymphocytic leukemia in patients treated for Hodgkin\u2019s disease","volume":"42","author":"Van der Velden","year":"1988","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJM199001043220102","article-title":"Leukemia following Hodgkin\u2019s disease","volume":"322","author":"Kaldor","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0105","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1056\/NEJM197903013000902","article-title":"Occurrence of non-Hodgkin\u2019s lymphoma after therapy for Hodgkin\u2019s disease","volume":"300","author":"Krikorian","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0110","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0889-8588(18)30558-6","article-title":"Second neoplasms in Hodgkin\u2019s disease: Current controversies","volume":"3","author":"Zarrabi","year":"1989","journal-title":"Hematol Oncol Clin North Am"},{"issue":"Suppl 2","key":"10.1093\/annonc\/3.suppl_4.S117_bb0115","first-page":"83","article-title":"Non-Hodgkin\u2019s lymphoma arising in patients treated for Hodgkin\u2019s disease in the BNLI: A 20-year experience","volume":"2","author":"Bennett","year":"1991","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0120","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM198801143180203","article-title":"Risk of second cancers after treatment for Hodgkin\u2019s disease","volume":"318","author":"Tucker","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0125","first-page":"219","article-title":"Summary: Multiple primary cancers in Connecticut, 1935-82","volume":"68","author":"Curtis","year":"1985","journal-title":"Natl Cancer Inst Monogr"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0130","first-page":"411","article-title":"Summary: Multiple primary cancers in Denmark, 1943-80","volume":"68","author":"Storm","year":"1985","journal-title":"Natl Cancer Inst Monogr"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0135","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/bjc.1987.201","article-title":"Second primary malignancy after Hodgkin\u2019s disease, ovarian cancer and cancer of the testis: A population-based cohort study","volume":"56","author":"Coleman","year":"1987","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0140","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/ijc.2910390506","article-title":"Second malignancies following testicular cancer, ovarian cancer and Hodgkin\u2019s disease: An international collaborative study among cancer registries","volume":"39","author":"Kaldor","year":"1987","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0145","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1002\/1097-0142(19880615)61:12<2541::AID-CNCR2820611225>3.0.CO;2-G","article-title":"Second cancer risk after treatment of Hodgkin\u2019s disease","volume":"61","author":"Boivin","year":"1988","journal-title":"Cancer"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0150","first-page":"463","article-title":"Acute granulocytic leukemia, a complication of therapeutic in Hodgkin\u2019s disease?","volume":"17","author":"Crosby","year":"1969","journal-title":"Clin Res"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0155","series-title":"Colloque Inserm Vol 196","first-page":"428","article-title":"Treatment Strategy in Hodgkin\u2019s Disease","author":"Somers","year":"1990"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0160","series-title":"International Classification of Diseases for Oncology","year":"1976"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bib0010","series-title":"Cancer Principles and practice of oncology","first-page":"1696","article-title":"Hodgkin\u2019s disease","author":"Hellman","year":"1989"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0165","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observation","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0170","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables (with discussion)","volume":"34","author":"Cox","year":"1972","journal-title":"J R Statist Soc B"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bib0015","series-title":"Proceedings of Second International Workshop on Statistical Database Management, Los Altos, CA","first-page":"124","article-title":"\u2018PIGAS\u2019: An interactive statistical database management system","author":"Wartelle","year":"1983"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0175","series-title":"BMDP Statistical Software Manual","author":"Dixon","year":"1985"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0180","first-page":"233","article-title":"Second primary cancers following treatment of Hodgkin\u2019s disease","volume":"72","author":"Boivin","year":"1984","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0185","first-page":"270","article-title":"Risk of secondary acute leukemia and pre-leukemia after Hodgkin\u2019s disease: The Institut Gustave-Roussy experience","volume":"117","author":"Henry-Amar","year":"1989","journal-title":"In Diehl V, Pfreundschuh, M Loeffler M (eds): New aspects in the diagnosis and treatment of Hodgkin\u2019s disease. Recent Results in Cancer Res"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bib0020","unstructured":"Henry-Amar M. Risk of second cancer after therapy for early stage Hodgkin disease: The EORTC experience [abstract 1878]. In Programs and Abstracts of the 17th International Congress of Radiology (Radiation Oncology Section), Paris, 1989, p 272."},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0190","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/jnci\/78.3.459","article-title":"Leukemia after therapy with alkylating agents for childhood cancer","volume":"78","author":"Tucker","year":"1987","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0195","first-page":"1035","article-title":"Second malignant neoplasms in patients successfully treated for Hodgkin\u2019s disease: A Cancer and Leukemia Group B study","volume":"66","author":"Glicksman","year":"1982","journal-title":"Cancer Treat Rep"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0200","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJM198703193161203","article-title":"Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin\u2019s disease","volume":"316","author":"Blayney","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0205","first-page":"911","article-title":"Second cancers after radiotherapy and chemotherapy for early stages of Hodgkin\u2019s disease","volume":"71","author":"Henry-Amar","year":"1983","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bib0025","series-title":"Malignant Lymphomas and Hodgkin\u2019s Disease: Experimental and Therapeutic Advances","first-page":"429","article-title":"Late complications of cytotoxic chemotherapy given for advanced Hodgkin\u2019s disease","author":"Waxman","year":"1985"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0210","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00254081","article-title":"Prolonged disease-free survival in MOPP-resistant Hodgkin\u2019s disease after treatment with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD)","volume":"2","author":"Santoro","year":"1979","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0215","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0360-3016(85)90357-8","article-title":"The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin\u2019s disease: 1962-1984","volume":"11","author":"Rosenberg","year":"1985","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0220","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/mpo.2950170525","article-title":"Second malignant neoplasms following childhood Hodgkin\u2019s disease: Treatment and splenectomy as risk factors","volume":"17","author":"Meadows","year":"1989","journal-title":"Med Ped Oncol"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0225","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00000421-198306000-00011","article-title":"Occurrence of nonlymphocytic leukemia in a prospective randomized study of treatment for Hodgkin\u2019s disease","volume":"6","author":"Gomez","year":"1983","journal-title":"Am J Clin Oncol"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0230","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1200\/JCO.1985.3.4.501","article-title":"Reduction of fatal complications from combined modality therapy in Hodgkin\u2019s disease","volume":"3","author":"Mauch","year":"1985","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0235","doi-asserted-by":"crossref","first-page":"44","DOI":"10.7326\/0003-4819-96-1-44","article-title":"Functional hyposplenia after splenic irradiation for Hodgkin\u2019s disease","volume":"96","author":"Coleman","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0240","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJM198001243020406","article-title":"Radiation-induced splenic atrophy in patients with Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphomas","volume":"302","author":"Dailey","year":"1980","journal-title":"N Eng J Med"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0245","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00000478-198106000-00002","article-title":"Splenic injury caused by therapeutic irradiation","volume":"5","author":"Dailey","year":"1980","journal-title":"Am J Surg Path"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0250","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1084\/jem.167.2.646","article-title":"Migration pattern of dendritic cells in the mouse: Homing to T cell-dependent areas of spleens, and binding with marginal zone","volume":"167","author":"Austyn","year":"1988","journal-title":"J Exp Med"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00007890-199001000-00001","article-title":"Migration patterns of dendritic leukocytes: Implications for transplantation","volume":"49","author":"Austyn","year":"1990","journal-title":"Transplantation"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0260","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1084\/jem.167.2.632","article-title":"Migration patterns of dendritic cells in the mouse: Traffic from the blood, and T cell-dependent and -independent entry to lymphoid tissue","volume":"167","author":"Kupiec-Weglinski","year":"1988","journal-title":"J Exp Med"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0265","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1084\/jem.171.1.307","article-title":"Migration of dendritic leukocytes from cardiac allografts into host spleens: A novel pathway for initiation of rejection","volume":"171","author":"Larsen","year":"1990","journal-title":"J Exp Med"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0270","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1084\/jem.172.5.1483","article-title":"Migration and maturation of Langerhans cells in skin transplants and ex-plants","volume":"172","author":"Larsen","year":"1990","journal-title":"J Exp Med"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0275","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1056\/NEJM198709103171112","article-title":"Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin\u2019s disease","volume":"317","author":"Li","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0280","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1056\/NEJM198709103171112","article-title":"Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin\u2019s disease","volume":"317","author":"Henry-Amar","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0285","first-page":"708","article-title":"Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin\u2019s disease","volume":"317","author":"Kaldor","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0290","first-page":"43","article-title":"Pathology panel for lymphoma clinical studies: A comprehensive analysis of cases accumulated since its inception","volume":"68","author":"Kim","year":"1982","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0295","first-page":"292","article-title":"Second neoplasms in Hodgkin\u2019s disease: Current controversies","volume":"8","author":"Zarrabi","year":"1989","journal-title":"Proc of ASCO. J Clin Oncol"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0300","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0305-7372(86)90015-0","article-title":"Concomitant illness in patients treated for Hodgkin\u2019s disease","volume":"13","author":"Bookman","year":"1986","journal-title":"Cancer Treat Rev"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0305","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/1097-0142(19801015)46:8<1735::AID-CNCR2820460806>3.0.CO;2-3","article-title":"Second malignancy in patients treated from Hodgkin\u2019s disease","volume":"46","author":"Baccarani","year":"1980","journal-title":"Cancer"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0310","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1002\/1097-0142(19811201)48:11<2386::AID-CNCR2820481109>3.0.CO;2-B","article-title":"Second malignant neoplasms in patients treated for Hodgkin\u2019s disease with radiotherapy or radiotherapy and chemotherapy","volume":"48","author":"Nelson","year":"1981","journal-title":"Cancer"},{"key":"10.1093\/annonc\/3.suppl_4.S117_bb0315","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/hon.2900040207","article-title":"Second primary malignant neoplasms in patients treated for Hodgkin\u2019s disease at St","volume":"4","author":"Dorreen","year":"1986","journal-title":"Bartholomew\u2019s hospital. Haematol Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341966299X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341966299X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/3\/suppl_4\/S117\/343665\/3-suppl_4-S117.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T10:38:32Z","timestamp":1714559912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092375341966299X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,9]]},"references-count":68,"alternative-id":["S092375341966299X"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/3.suppl_4.s117","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1992,9]]}}}